GERMANY — At an undisclosed site in Germany’s Bavaria state, pharmaceutical CEO Philip Schetter opens a 75-centimeter (30-inch) thick steel door that secures his wares: vast amounts of cannabis.
“Better safe than sorry,” he said during a visit to the compound run by Cantourage, a producer and distributor of cannabis-based medicinal products.
Register to read this story and more for free.
Signing up for an account helps us improve your browsing experience.
OR
See our subscription options.